"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","characteristics_ch1.2","characteristics_ch1.3","characteristics_ch1.4","characteristics_ch1.5","characteristics_ch1.6","characteristics_ch1.7","molecule_ch1","extract_protocol_ch1","extract_protocol_ch1.1","taxid_ch1","data_processing","data_processing.1","data_processing.2","data_processing.3","platform_id","contact_name","contact_email","contact_phone","contact_department","contact_institute","contact_address","contact_city","contact_state","contact_zip/postal_code","contact_country","data_row_count","instrument_model","library_selection","library_source","library_strategy","relation","relation.1","supplementary_file_1","1p/19q:ch1","atrx:ch1","idh1:ch1","mgmt:ch1","molecule subtype:ch1","pre-operation radiology:ch1","sample type:ch1","treatment effect:ch1"
"GSM3467238","GBM1","GSM3467238","Public on Nov 14 2018","Nov 13 2018","Nov 14 2018","SRA","1","IDH-wildtype glioblastoma_Serum_Exosome","Homo sapiens","sample type: glioblastoma","idh1: wt","atrx: +","mgmt: Unmeth","1p/19q: not performed","pre-operation radiology: T2 hyperintense; FLAIR high signal; contrast enhancement (recurrence)","treatment effect: Focal radionecrosis","molecule subtype: small RNA","total RNA","Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science). Then, Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer’s protocol.","Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer’s instructions.","9606","Illumina Casava1.7 software used for basecalling.","Data pre-processing was performed using a pipeline comprising of adapter trimming (cutadapt), followed by genome alignment to human genome hg 19 using Bowtie (18 bp seed, 1 error in seed, quality score sum of mismatches<70). Where multiple best strata alignments existed, tags were randomly assigned to one of those coordinates. Tags were annotated against mirBase 20 and filtered for at most one base error within the tag.","Counts for each miRNA were tabulated and adjusted to counts per million miRNAs passing the mismatch filter.","Supplementary_files_format_and_content: All samples achieved miRNA read counts >45,000 read counts and miRNAs with low abundance (<50 read counts across more than 20% of samples) were removed.","GPL11154","Fatemeh,,Vafaee","f.vafaee@unsw.edu.au","0061403012736","School of Biotechnology and Biomolecular Sciences","University of New South Wales","Gate 11 Botany Street, UNSW Sydney, School of BABS","Sydney","UNSW","2052","Australia","0","Illumina HiSeq 2000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10415991","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5005712","NONE","not performed","+","wt","Unmeth","small RNA","T2 hyperintense; FLAIR high signal; contrast enhancement (recurrence)","glioblastoma","Focal radionecrosis"
"GSM3467239","GBM2","GSM3467239","Public on Nov 14 2018","Nov 13 2018","Nov 14 2018","SRA","1","IDH-wildtype glioblastoma_Serum_Exosome","Homo sapiens","sample type: glioblastoma","idh1: wt","atrx: +","mgmt: Unmeth","1p/19q: not performed","pre-operation radiology: Heterogeneous lesions with subtle diffusion restriction; extensive peri-tumor edema","treatment effect: No prior Rx","molecule subtype: small RNA","total RNA","Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science). Then, Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer’s protocol.","Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer’s instructions.","9606","Illumina Casava1.7 software used for basecalling.","Data pre-processing was performed using a pipeline comprising of adapter trimming (cutadapt), followed by genome alignment to human genome hg 19 using Bowtie (18 bp seed, 1 error in seed, quality score sum of mismatches<70). Where multiple best strata alignments existed, tags were randomly assigned to one of those coordinates. Tags were annotated against mirBase 20 and filtered for at most one base error within the tag.","Counts for each miRNA were tabulated and adjusted to counts per million miRNAs passing the mismatch filter.","Supplementary_files_format_and_content: All samples achieved miRNA read counts >45,000 read counts and miRNAs with low abundance (<50 read counts across more than 20% of samples) were removed.","GPL11154","Fatemeh,,Vafaee","f.vafaee@unsw.edu.au","0061403012736","School of Biotechnology and Biomolecular Sciences","University of New South Wales","Gate 11 Botany Street, UNSW Sydney, School of BABS","Sydney","UNSW","2052","Australia","0","Illumina HiSeq 2000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10415990","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5005713","NONE","not performed","+","wt","Unmeth","small RNA","Heterogeneous lesions with subtle diffusion restriction; extensive peri-tumor edema","glioblastoma","No prior Rx"
"GSM3467240","GBM3","GSM3467240","Public on Nov 14 2018","Nov 13 2018","Nov 14 2018","SRA","1","IDH-wildtype glioblastoma_Serum_Exosome","Homo sapiens","sample type: glioblastoma","idh1: wt","atrx: +","mgmt: Unmeth","1p/19q: not performed","pre-operation radiology: T2 hyperintense; contrast enhancement (recurrence)","treatment effect: Focal radionecrosis","molecule subtype: small RNA","total RNA","Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science). Then, Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer’s protocol.","Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer’s instructions.","9606","Illumina Casava1.7 software used for basecalling.","Data pre-processing was performed using a pipeline comprising of adapter trimming (cutadapt), followed by genome alignment to human genome hg 19 using Bowtie (18 bp seed, 1 error in seed, quality score sum of mismatches<70). Where multiple best strata alignments existed, tags were randomly assigned to one of those coordinates. Tags were annotated against mirBase 20 and filtered for at most one base error within the tag.","Counts for each miRNA were tabulated and adjusted to counts per million miRNAs passing the mismatch filter.","Supplementary_files_format_and_content: All samples achieved miRNA read counts >45,000 read counts and miRNAs with low abundance (<50 read counts across more than 20% of samples) were removed.","GPL11154","Fatemeh,,Vafaee","f.vafaee@unsw.edu.au","0061403012736","School of Biotechnology and Biomolecular Sciences","University of New South Wales","Gate 11 Botany Street, UNSW Sydney, School of BABS","Sydney","UNSW","2052","Australia","0","Illumina HiSeq 2000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10415989","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5005714","NONE","not performed","+","wt","Unmeth","small RNA","T2 hyperintense; contrast enhancement (recurrence)","glioblastoma","Focal radionecrosis"
"GSM3467241","GBM4","GSM3467241","Public on Nov 14 2018","Nov 13 2018","Nov 14 2018","SRA","1","IDH-wildtype glioblastoma_Serum_Exosome","Homo sapiens","sample type: glioblastoma","idh1: wt","atrx: +","mgmt: Meth","1p/19q: not performed","pre-operation radiology: Contrast enhancement - post surgical change","treatment effect: No prior Rx","molecule subtype: small RNA","total RNA","Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science). Then, Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer’s protocol.","Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer’s instructions.","9606","Illumina Casava1.7 software used for basecalling.","Data pre-processing was performed using a pipeline comprising of adapter trimming (cutadapt), followed by genome alignment to human genome hg 19 using Bowtie (18 bp seed, 1 error in seed, quality score sum of mismatches<70). Where multiple best strata alignments existed, tags were randomly assigned to one of those coordinates. Tags were annotated against mirBase 20 and filtered for at most one base error within the tag.","Counts for each miRNA were tabulated and adjusted to counts per million miRNAs passing the mismatch filter.","Supplementary_files_format_and_content: All samples achieved miRNA read counts >45,000 read counts and miRNAs with low abundance (<50 read counts across more than 20% of samples) were removed.","GPL11154","Fatemeh,,Vafaee","f.vafaee@unsw.edu.au","0061403012736","School of Biotechnology and Biomolecular Sciences","University of New South Wales","Gate 11 Botany Street, UNSW Sydney, School of BABS","Sydney","UNSW","2052","Australia","0","Illumina HiSeq 2000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10415988","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5005715","NONE","not performed","+","wt","Meth","small RNA","Contrast enhancement - post surgical change","glioblastoma","No prior Rx"
"GSM3467242","GBM5","GSM3467242","Public on Nov 14 2018","Nov 13 2018","Nov 14 2018","SRA","1","IDH-wildtype glioblastoma_Serum_Exosome","Homo sapiens","sample type: glioblastoma","idh1: wt","atrx: +","mgmt: Unmeth","1p/19q: not performed","pre-operation radiology: T2 - hyperintense; T1 heterogenous intensity; contrast enhancing","treatment effect: No prior Rx","molecule subtype: small RNA","total RNA","Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science). Then, Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer’s protocol.","Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer’s instructions.","9606","Illumina Casava1.7 software used for basecalling.","Data pre-processing was performed using a pipeline comprising of adapter trimming (cutadapt), followed by genome alignment to human genome hg 19 using Bowtie (18 bp seed, 1 error in seed, quality score sum of mismatches<70). Where multiple best strata alignments existed, tags were randomly assigned to one of those coordinates. Tags were annotated against mirBase 20 and filtered for at most one base error within the tag.","Counts for each miRNA were tabulated and adjusted to counts per million miRNAs passing the mismatch filter.","Supplementary_files_format_and_content: All samples achieved miRNA read counts >45,000 read counts and miRNAs with low abundance (<50 read counts across more than 20% of samples) were removed.","GPL11154","Fatemeh,,Vafaee","f.vafaee@unsw.edu.au","0061403012736","School of Biotechnology and Biomolecular Sciences","University of New South Wales","Gate 11 Botany Street, UNSW Sydney, School of BABS","Sydney","UNSW","2052","Australia","0","Illumina HiSeq 2000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10415987","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5005716","NONE","not performed","+","wt","Unmeth","small RNA","T2 - hyperintense; T1 heterogenous intensity; contrast enhancing","glioblastoma","No prior Rx"
"GSM3467243","GBM6","GSM3467243","Public on Nov 14 2018","Nov 13 2018","Nov 14 2018","SRA","1","IDH-wildtype glioblastoma_Serum_Exosome","Homo sapiens","sample type: glioblastoma","idh1: wt","atrx: +","mgmt: borderline","1p/19q: not performed","pre-operation radiology: T2 hyperintense; central restricted diffusion; rim enhancing","treatment effect: No prior Rx","molecule subtype: small RNA","total RNA","Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science). Then, Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer’s protocol.","Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer’s instructions.","9606","Illumina Casava1.7 software used for basecalling.","Data pre-processing was performed using a pipeline comprising of adapter trimming (cutadapt), followed by genome alignment to human genome hg 19 using Bowtie (18 bp seed, 1 error in seed, quality score sum of mismatches<70). Where multiple best strata alignments existed, tags were randomly assigned to one of those coordinates. Tags were annotated against mirBase 20 and filtered for at most one base error within the tag.","Counts for each miRNA were tabulated and adjusted to counts per million miRNAs passing the mismatch filter.","Supplementary_files_format_and_content: All samples achieved miRNA read counts >45,000 read counts and miRNAs with low abundance (<50 read counts across more than 20% of samples) were removed.","GPL11154","Fatemeh,,Vafaee","f.vafaee@unsw.edu.au","0061403012736","School of Biotechnology and Biomolecular Sciences","University of New South Wales","Gate 11 Botany Street, UNSW Sydney, School of BABS","Sydney","UNSW","2052","Australia","0","Illumina HiSeq 2000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10415986","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5005717","NONE","not performed","+","wt","borderline","small RNA","T2 hyperintense; central restricted diffusion; rim enhancing","glioblastoma","No prior Rx"
"GSM3467244","GBM7","GSM3467244","Public on Nov 14 2018","Nov 13 2018","Nov 14 2018","SRA","1","IDH-wildtype glioblastoma_Serum_Exosome","Homo sapiens","sample type: glioblastoma","idh1: wt","atrx: +","mgmt: Unmeth","1p/19q: not performed","pre-operation radiology: T2 hyperintense; T1 hypointense; rim enhancing lesion","treatment effect: No prior Rx","molecule subtype: small RNA","total RNA","Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science). Then, Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer’s protocol.","Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer’s instructions.","9606","Illumina Casava1.7 software used for basecalling.","Data pre-processing was performed using a pipeline comprising of adapter trimming (cutadapt), followed by genome alignment to human genome hg 19 using Bowtie (18 bp seed, 1 error in seed, quality score sum of mismatches<70). Where multiple best strata alignments existed, tags were randomly assigned to one of those coordinates. Tags were annotated against mirBase 20 and filtered for at most one base error within the tag.","Counts for each miRNA were tabulated and adjusted to counts per million miRNAs passing the mismatch filter.","Supplementary_files_format_and_content: All samples achieved miRNA read counts >45,000 read counts and miRNAs with low abundance (<50 read counts across more than 20% of samples) were removed.","GPL11154","Fatemeh,,Vafaee","f.vafaee@unsw.edu.au","0061403012736","School of Biotechnology and Biomolecular Sciences","University of New South Wales","Gate 11 Botany Street, UNSW Sydney, School of BABS","Sydney","UNSW","2052","Australia","0","Illumina HiSeq 2000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10415985","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5005718","NONE","not performed","+","wt","Unmeth","small RNA","T2 hyperintense; T1 hypointense; rim enhancing lesion","glioblastoma","No prior Rx"
"GSM3467245","GBM8","GSM3467245","Public on Nov 14 2018","Nov 13 2018","Nov 14 2018","SRA","1","IDH-wildtype glioblastoma_Serum_Exosome","Homo sapiens","sample type: glioblastoma","idh1: wt","atrx: +","mgmt: Unmeth","1p/19q: not performed","pre-operation radiology: T2 hyperintense; FLAIR high signal; contrast enhancement","treatment effect: No prior Rx","molecule subtype: small RNA","total RNA","Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science). Then, Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer’s protocol.","Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer’s instructions.","9606","Illumina Casava1.7 software used for basecalling.","Data pre-processing was performed using a pipeline comprising of adapter trimming (cutadapt), followed by genome alignment to human genome hg 19 using Bowtie (18 bp seed, 1 error in seed, quality score sum of mismatches<70). Where multiple best strata alignments existed, tags were randomly assigned to one of those coordinates. Tags were annotated against mirBase 20 and filtered for at most one base error within the tag.","Counts for each miRNA were tabulated and adjusted to counts per million miRNAs passing the mismatch filter.","Supplementary_files_format_and_content: All samples achieved miRNA read counts >45,000 read counts and miRNAs with low abundance (<50 read counts across more than 20% of samples) were removed.","GPL11154","Fatemeh,,Vafaee","f.vafaee@unsw.edu.au","0061403012736","School of Biotechnology and Biomolecular Sciences","University of New South Wales","Gate 11 Botany Street, UNSW Sydney, School of BABS","Sydney","UNSW","2052","Australia","0","Illumina HiSeq 2000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10415984","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5005719","NONE","not performed","+","wt","Unmeth","small RNA","T2 hyperintense; FLAIR high signal; contrast enhancement","glioblastoma","No prior Rx"
"GSM3467246","GBM9","GSM3467246","Public on Nov 14 2018","Nov 13 2018","Nov 14 2018","SRA","1","IDH-wildtype glioblastoma_Serum_Exosome","Homo sapiens","sample type: glioblastoma","idh1: wt","atrx: +","mgmt: Meth","1p/19q: not performed","pre-operation radiology: Rim enhancing lesion","treatment effect: No prior Rx","molecule subtype: small RNA","total RNA","Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science). Then, Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer’s protocol.","Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer’s instructions.","9606","Illumina Casava1.7 software used for basecalling.","Data pre-processing was performed using a pipeline comprising of adapter trimming (cutadapt), followed by genome alignment to human genome hg 19 using Bowtie (18 bp seed, 1 error in seed, quality score sum of mismatches<70). Where multiple best strata alignments existed, tags were randomly assigned to one of those coordinates. Tags were annotated against mirBase 20 and filtered for at most one base error within the tag.","Counts for each miRNA were tabulated and adjusted to counts per million miRNAs passing the mismatch filter.","Supplementary_files_format_and_content: All samples achieved miRNA read counts >45,000 read counts and miRNAs with low abundance (<50 read counts across more than 20% of samples) were removed.","GPL11154","Fatemeh,,Vafaee","f.vafaee@unsw.edu.au","0061403012736","School of Biotechnology and Biomolecular Sciences","University of New South Wales","Gate 11 Botany Street, UNSW Sydney, School of BABS","Sydney","UNSW","2052","Australia","0","Illumina HiSeq 2000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10415983","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5005720","NONE","not performed","+","wt","Meth","small RNA","Rim enhancing lesion","glioblastoma","No prior Rx"
"GSM3467247","GBM10","GSM3467247","Public on Nov 14 2018","Nov 13 2018","Nov 14 2018","SRA","1","IDH-wildtype glioblastoma_Serum_Exosome","Homo sapiens","sample type: glioblastoma","idh1: wt","atrx: +","mgmt: Meth","1p/19q: not performed","pre-operation radiology: Rim enhancing lesion with central restricted diffusion","treatment effect: No prior Rx","molecule subtype: small RNA","total RNA","Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science). Then, Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer’s protocol.","Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer’s instructions.","9606","Illumina Casava1.7 software used for basecalling.","Data pre-processing was performed using a pipeline comprising of adapter trimming (cutadapt), followed by genome alignment to human genome hg 19 using Bowtie (18 bp seed, 1 error in seed, quality score sum of mismatches<70). Where multiple best strata alignments existed, tags were randomly assigned to one of those coordinates. Tags were annotated against mirBase 20 and filtered for at most one base error within the tag.","Counts for each miRNA were tabulated and adjusted to counts per million miRNAs passing the mismatch filter.","Supplementary_files_format_and_content: All samples achieved miRNA read counts >45,000 read counts and miRNAs with low abundance (<50 read counts across more than 20% of samples) were removed.","GPL11154","Fatemeh,,Vafaee","f.vafaee@unsw.edu.au","0061403012736","School of Biotechnology and Biomolecular Sciences","University of New South Wales","Gate 11 Botany Street, UNSW Sydney, School of BABS","Sydney","UNSW","2052","Australia","0","Illumina HiSeq 2000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10415982","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5005721","NONE","not performed","+","wt","Meth","small RNA","Rim enhancing lesion with central restricted diffusion","glioblastoma","No prior Rx"
"GSM3467248","GBM11","GSM3467248","Public on Nov 14 2018","Nov 13 2018","Nov 14 2018","SRA","1","IDH-wildtype glioblastoma_Serum_Exosome","Homo sapiens","sample type: glioblastoma","idh1: wt","atrx: +","mgmt: Unmeth","1p/19q: not performed","pre-operation radiology: Rim enhancing lesion with central restricted diffusion","treatment effect: Treatment effects (tumour necrosis with mineralisation and hyalinised vessels)","molecule subtype: small RNA","total RNA","Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science). Then, Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer’s protocol.","Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer’s instructions.","9606","Illumina Casava1.7 software used for basecalling.","Data pre-processing was performed using a pipeline comprising of adapter trimming (cutadapt), followed by genome alignment to human genome hg 19 using Bowtie (18 bp seed, 1 error in seed, quality score sum of mismatches<70). Where multiple best strata alignments existed, tags were randomly assigned to one of those coordinates. Tags were annotated against mirBase 20 and filtered for at most one base error within the tag.","Counts for each miRNA were tabulated and adjusted to counts per million miRNAs passing the mismatch filter.","Supplementary_files_format_and_content: All samples achieved miRNA read counts >45,000 read counts and miRNAs with low abundance (<50 read counts across more than 20% of samples) were removed.","GPL11154","Fatemeh,,Vafaee","f.vafaee@unsw.edu.au","0061403012736","School of Biotechnology and Biomolecular Sciences","University of New South Wales","Gate 11 Botany Street, UNSW Sydney, School of BABS","Sydney","UNSW","2052","Australia","0","Illumina HiSeq 2000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10415981","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5005722","NONE","not performed","+","wt","Unmeth","small RNA","Rim enhancing lesion with central restricted diffusion","glioblastoma","Treatment effects (tumour necrosis with mineralisation and hyalinised vessels)"
"GSM3467249","GBM12","GSM3467249","Public on Nov 14 2018","Nov 13 2018","Nov 14 2018","SRA","1","IDH-wildtype glioblastoma_Serum_Exosome","Homo sapiens","sample type: glioblastoma","idh1: wt","atrx: +","mgmt: Unmeth","1p/19q: not performed","pre-operation radiology: Heterogenously enhancing mass","treatment effect: No prior Rx","molecule subtype: small RNA","total RNA","Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science). Then, Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer’s protocol.","Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer’s instructions.","9606","Illumina Casava1.7 software used for basecalling.","Data pre-processing was performed using a pipeline comprising of adapter trimming (cutadapt), followed by genome alignment to human genome hg 19 using Bowtie (18 bp seed, 1 error in seed, quality score sum of mismatches<70). Where multiple best strata alignments existed, tags were randomly assigned to one of those coordinates. Tags were annotated against mirBase 20 and filtered for at most one base error within the tag.","Counts for each miRNA were tabulated and adjusted to counts per million miRNAs passing the mismatch filter.","Supplementary_files_format_and_content: All samples achieved miRNA read counts >45,000 read counts and miRNAs with low abundance (<50 read counts across more than 20% of samples) were removed.","GPL11154","Fatemeh,,Vafaee","f.vafaee@unsw.edu.au","0061403012736","School of Biotechnology and Biomolecular Sciences","University of New South Wales","Gate 11 Botany Street, UNSW Sydney, School of BABS","Sydney","UNSW","2052","Australia","0","Illumina HiSeq 2000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10415980","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5005723","NONE","not performed","+","wt","Unmeth","small RNA","Heterogenously enhancing mass","glioblastoma","No prior Rx"
"GSM3467250","GII-III.1","GSM3467250","Public on Nov 14 2018","Nov 13 2018","Nov 14 2018","SRA","1","IDH-mutant glioma grades II-III_Serum_Exosome","Homo sapiens","sample type: glioblastoma","idh1: mut","atrx: +","mgmt: Meth","1p/19q: -","pre-operation radiology: High FLAIR signal","treatment effect: No prior Rx","molecule subtype: small RNA","total RNA","Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science). Then, Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer’s protocol.","Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer’s instructions.","9606","Illumina Casava1.7 software used for basecalling.","Data pre-processing was performed using a pipeline comprising of adapter trimming (cutadapt), followed by genome alignment to human genome hg 19 using Bowtie (18 bp seed, 1 error in seed, quality score sum of mismatches<70). Where multiple best strata alignments existed, tags were randomly assigned to one of those coordinates. Tags were annotated against mirBase 20 and filtered for at most one base error within the tag.","Counts for each miRNA were tabulated and adjusted to counts per million miRNAs passing the mismatch filter.","Supplementary_files_format_and_content: All samples achieved miRNA read counts >45,000 read counts and miRNAs with low abundance (<50 read counts across more than 20% of samples) were removed.","GPL11154","Fatemeh,,Vafaee","f.vafaee@unsw.edu.au","0061403012736","School of Biotechnology and Biomolecular Sciences","University of New South Wales","Gate 11 Botany Street, UNSW Sydney, School of BABS","Sydney","UNSW","2052","Australia","0","Illumina HiSeq 2000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10415979","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5005724","NONE","-","+","mut","Meth","small RNA","High FLAIR signal","glioblastoma","No prior Rx"
"GSM3467251","GII-III.2","GSM3467251","Public on Nov 14 2018","Nov 13 2018","Nov 14 2018","SRA","1","IDH-mutant glioma grades II-III_Serum_Exosome","Homo sapiens","sample type: glioblastoma","idh1: mut","atrx: -","mgmt: Meth","1p/19q: 19q loss","pre-operation radiology: T2 - hyperintense; T1 hypointense; rim peripheral restricted diffusion","treatment effect: No prior Rx","molecule subtype: small RNA","total RNA","Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science). Then, Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer’s protocol.","Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer’s instructions.","9606","Illumina Casava1.7 software used for basecalling.","Data pre-processing was performed using a pipeline comprising of adapter trimming (cutadapt), followed by genome alignment to human genome hg 19 using Bowtie (18 bp seed, 1 error in seed, quality score sum of mismatches<70). Where multiple best strata alignments existed, tags were randomly assigned to one of those coordinates. Tags were annotated against mirBase 20 and filtered for at most one base error within the tag.","Counts for each miRNA were tabulated and adjusted to counts per million miRNAs passing the mismatch filter.","Supplementary_files_format_and_content: All samples achieved miRNA read counts >45,000 read counts and miRNAs with low abundance (<50 read counts across more than 20% of samples) were removed.","GPL11154","Fatemeh,,Vafaee","f.vafaee@unsw.edu.au","0061403012736","School of Biotechnology and Biomolecular Sciences","University of New South Wales","Gate 11 Botany Street, UNSW Sydney, School of BABS","Sydney","UNSW","2052","Australia","0","Illumina HiSeq 2000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10416004","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5005725","NONE","19q loss","-","mut","Meth","small RNA","T2 - hyperintense; T1 hypointense; rim peripheral restricted diffusion","glioblastoma","No prior Rx"
"GSM3467252","GII-III.3","GSM3467252","Public on Nov 14 2018","Nov 13 2018","Nov 14 2018","SRA","1","IDH-mutant glioma grades II-III_Serum_Exosome","Homo sapiens","sample type: glioblastoma","idh1: mut","atrx: -","mgmt: Meth","1p/19q: not performed","pre-operation radiology: T2 - hyperintense; FLAIR - high signal; no contrast enhancement (recurrence)","treatment effect: No Rx effects","molecule subtype: small RNA","total RNA","Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science). Then, Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer’s protocol.","Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer’s instructions.","9606","Illumina Casava1.7 software used for basecalling.","Data pre-processing was performed using a pipeline comprising of adapter trimming (cutadapt), followed by genome alignment to human genome hg 19 using Bowtie (18 bp seed, 1 error in seed, quality score sum of mismatches<70). Where multiple best strata alignments existed, tags were randomly assigned to one of those coordinates. Tags were annotated against mirBase 20 and filtered for at most one base error within the tag.","Counts for each miRNA were tabulated and adjusted to counts per million miRNAs passing the mismatch filter.","Supplementary_files_format_and_content: All samples achieved miRNA read counts >45,000 read counts and miRNAs with low abundance (<50 read counts across more than 20% of samples) were removed.","GPL11154","Fatemeh,,Vafaee","f.vafaee@unsw.edu.au","0061403012736","School of Biotechnology and Biomolecular Sciences","University of New South Wales","Gate 11 Botany Street, UNSW Sydney, School of BABS","Sydney","UNSW","2052","Australia","0","Illumina HiSeq 2000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10416003","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5005726","NONE","not performed","-","mut","Meth","small RNA","T2 - hyperintense; FLAIR - high signal; no contrast enhancement (recurrence)","glioblastoma","No Rx effects"
"GSM3467253","GII-III.4","GSM3467253","Public on Nov 14 2018","Nov 13 2018","Nov 14 2018","SRA","1","IDH-mutant glioma grades II-III_Serum_Exosome","Homo sapiens","sample type: glioblastoma","idh1: mut","atrx: -","mgmt: borderline","1p/19q: not performed","pre-operation radiology: T2 - hyperintense; FLAIR - patchy suppression","treatment effect: No prior Rx","molecule subtype: small RNA","total RNA","Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science). Then, Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer’s protocol.","Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer’s instructions.","9606","Illumina Casava1.7 software used for basecalling.","Data pre-processing was performed using a pipeline comprising of adapter trimming (cutadapt), followed by genome alignment to human genome hg 19 using Bowtie (18 bp seed, 1 error in seed, quality score sum of mismatches<70). Where multiple best strata alignments existed, tags were randomly assigned to one of those coordinates. Tags were annotated against mirBase 20 and filtered for at most one base error within the tag.","Counts for each miRNA were tabulated and adjusted to counts per million miRNAs passing the mismatch filter.","Supplementary_files_format_and_content: All samples achieved miRNA read counts >45,000 read counts and miRNAs with low abundance (<50 read counts across more than 20% of samples) were removed.","GPL11154","Fatemeh,,Vafaee","f.vafaee@unsw.edu.au","0061403012736","School of Biotechnology and Biomolecular Sciences","University of New South Wales","Gate 11 Botany Street, UNSW Sydney, School of BABS","Sydney","UNSW","2052","Australia","0","Illumina HiSeq 2000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10415955","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5005727","NONE","not performed","-","mut","borderline","small RNA","T2 - hyperintense; FLAIR - patchy suppression","glioblastoma","No prior Rx"
"GSM3467254","GII-III.5","GSM3467254","Public on Nov 14 2018","Nov 13 2018","Nov 14 2018","SRA","1","IDH-mutant glioma grades II-III_Serum_Exosome","Homo sapiens","sample type: glioblastoma","idh1: mut","atrx: -","mgmt: Meth","1p/19q: -","pre-operation radiology: T2 - hyperintense; T1 - isointense; no contrast enhancement (recurrence)","treatment effect: Rare hyalinised vessels","molecule subtype: small RNA","total RNA","Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science). Then, Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer’s protocol.","Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer’s instructions.","9606","Illumina Casava1.7 software used for basecalling.","Data pre-processing was performed using a pipeline comprising of adapter trimming (cutadapt), followed by genome alignment to human genome hg 19 using Bowtie (18 bp seed, 1 error in seed, quality score sum of mismatches<70). Where multiple best strata alignments existed, tags were randomly assigned to one of those coordinates. Tags were annotated against mirBase 20 and filtered for at most one base error within the tag.","Counts for each miRNA were tabulated and adjusted to counts per million miRNAs passing the mismatch filter.","Supplementary_files_format_and_content: All samples achieved miRNA read counts >45,000 read counts and miRNAs with low abundance (<50 read counts across more than 20% of samples) were removed.","GPL11154","Fatemeh,,Vafaee","f.vafaee@unsw.edu.au","0061403012736","School of Biotechnology and Biomolecular Sciences","University of New South Wales","Gate 11 Botany Street, UNSW Sydney, School of BABS","Sydney","UNSW","2052","Australia","0","Illumina HiSeq 2000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10416002","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5005728","NONE","-","-","mut","Meth","small RNA","T2 - hyperintense; T1 - isointense; no contrast enhancement (recurrence)","glioblastoma","Rare hyalinised vessels"
"GSM3467255","GII-III.6","GSM3467255","Public on Nov 14 2018","Nov 13 2018","Nov 14 2018","SRA","1","IDH-mutant glioma grades II-III_Serum_Exosome","Homo sapiens","sample type: glioblastoma","idh1: mut","atrx: +/-","mgmt: Meth","1p/19q: not performed","pre-operation radiology: T1 - hyperintense; contrast enhancing (recurrence)","treatment effect: Radionecrosis","molecule subtype: small RNA","total RNA","Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science). Then, Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer’s protocol.","Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer’s instructions.","9606","Illumina Casava1.7 software used for basecalling.","Data pre-processing was performed using a pipeline comprising of adapter trimming (cutadapt), followed by genome alignment to human genome hg 19 using Bowtie (18 bp seed, 1 error in seed, quality score sum of mismatches<70). Where multiple best strata alignments existed, tags were randomly assigned to one of those coordinates. Tags were annotated against mirBase 20 and filtered for at most one base error within the tag.","Counts for each miRNA were tabulated and adjusted to counts per million miRNAs passing the mismatch filter.","Supplementary_files_format_and_content: All samples achieved miRNA read counts >45,000 read counts and miRNAs with low abundance (<50 read counts across more than 20% of samples) were removed.","GPL11154","Fatemeh,,Vafaee","f.vafaee@unsw.edu.au","0061403012736","School of Biotechnology and Biomolecular Sciences","University of New South Wales","Gate 11 Botany Street, UNSW Sydney, School of BABS","Sydney","UNSW","2052","Australia","0","Illumina HiSeq 2000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10416001","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5005729","NONE","not performed","+/-","mut","Meth","small RNA","T1 - hyperintense; contrast enhancing (recurrence)","glioblastoma","Radionecrosis"
"GSM3467256","GII-III.7","GSM3467256","Public on Nov 14 2018","Nov 13 2018","Nov 14 2018","SRA","1","IDH-mutant glioma grades II-III_Serum_Exosome","Homo sapiens","sample type: glioblastoma","idh1: mut","atrx: +","mgmt: Meth","1p/19q: 1p/19q codeletion","pre-operation radiology: Contrast enhancement; central diffusion restriction","treatment effect: Coagulative necrosis with microCa2+","molecule subtype: small RNA","total RNA","Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science). Then, Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer’s protocol.","Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer’s instructions.","9606","Illumina Casava1.7 software used for basecalling.","Data pre-processing was performed using a pipeline comprising of adapter trimming (cutadapt), followed by genome alignment to human genome hg 19 using Bowtie (18 bp seed, 1 error in seed, quality score sum of mismatches<70). Where multiple best strata alignments existed, tags were randomly assigned to one of those coordinates. Tags were annotated against mirBase 20 and filtered for at most one base error within the tag.","Counts for each miRNA were tabulated and adjusted to counts per million miRNAs passing the mismatch filter.","Supplementary_files_format_and_content: All samples achieved miRNA read counts >45,000 read counts and miRNAs with low abundance (<50 read counts across more than 20% of samples) were removed.","GPL11154","Fatemeh,,Vafaee","f.vafaee@unsw.edu.au","0061403012736","School of Biotechnology and Biomolecular Sciences","University of New South Wales","Gate 11 Botany Street, UNSW Sydney, School of BABS","Sydney","UNSW","2052","Australia","0","Illumina HiSeq 2000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10416000","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5005730","NONE","1p/19q codeletion","+","mut","Meth","small RNA","Contrast enhancement; central diffusion restriction","glioblastoma","Coagulative necrosis with microCa2+"
"GSM3467257","GII-III.8","GSM3467257","Public on Nov 14 2018","Nov 13 2018","Nov 14 2018","SRA","1","IDH-mutant glioma grades II-III_Serum_Exosome","Homo sapiens","sample type: glioblastoma","idh1: mut","atrx: +","mgmt: Meth","1p/19q: 1p/19q codeletion","pre-operation radiology: T2 hyperintense; contrast enhancement (recurrence)","treatment effect: No Rx effects","molecule subtype: small RNA","total RNA","Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science). Then, Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer’s protocol.","Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer’s instructions.","9606","Illumina Casava1.7 software used for basecalling.","Data pre-processing was performed using a pipeline comprising of adapter trimming (cutadapt), followed by genome alignment to human genome hg 19 using Bowtie (18 bp seed, 1 error in seed, quality score sum of mismatches<70). Where multiple best strata alignments existed, tags were randomly assigned to one of those coordinates. Tags were annotated against mirBase 20 and filtered for at most one base error within the tag.","Counts for each miRNA were tabulated and adjusted to counts per million miRNAs passing the mismatch filter.","Supplementary_files_format_and_content: All samples achieved miRNA read counts >45,000 read counts and miRNAs with low abundance (<50 read counts across more than 20% of samples) were removed.","GPL11154","Fatemeh,,Vafaee","f.vafaee@unsw.edu.au","0061403012736","School of Biotechnology and Biomolecular Sciences","University of New South Wales","Gate 11 Botany Street, UNSW Sydney, School of BABS","Sydney","UNSW","2052","Australia","0","Illumina HiSeq 2000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10415999","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5005731","NONE","1p/19q codeletion","+","mut","Meth","small RNA","T2 hyperintense; contrast enhancement (recurrence)","glioblastoma","No Rx effects"
"GSM3467258","GII-III.9","GSM3467258","Public on Nov 14 2018","Nov 13 2018","Nov 14 2018","SRA","1","IDH-mutant glioma grades II-III_Serum_Exosome","Homo sapiens","sample type: glioblastoma","idh1: mut","atrx: +","mgmt: Meth","1p/19q: 1p/19q codeletion","pre-operation radiology: T2 hyperintense; contrast enhancement anteriorly","treatment effect: No prior Rx","molecule subtype: small RNA","total RNA","Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science). Then, Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer’s protocol.","Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer’s instructions.","9606","Illumina Casava1.7 software used for basecalling.","Data pre-processing was performed using a pipeline comprising of adapter trimming (cutadapt), followed by genome alignment to human genome hg 19 using Bowtie (18 bp seed, 1 error in seed, quality score sum of mismatches<70). Where multiple best strata alignments existed, tags were randomly assigned to one of those coordinates. Tags were annotated against mirBase 20 and filtered for at most one base error within the tag.","Counts for each miRNA were tabulated and adjusted to counts per million miRNAs passing the mismatch filter.","Supplementary_files_format_and_content: All samples achieved miRNA read counts >45,000 read counts and miRNAs with low abundance (<50 read counts across more than 20% of samples) were removed.","GPL11154","Fatemeh,,Vafaee","f.vafaee@unsw.edu.au","0061403012736","School of Biotechnology and Biomolecular Sciences","University of New South Wales","Gate 11 Botany Street, UNSW Sydney, School of BABS","Sydney","UNSW","2052","Australia","0","Illumina HiSeq 2000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10415998","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5005732","NONE","1p/19q codeletion","+","mut","Meth","small RNA","T2 hyperintense; contrast enhancement anteriorly","glioblastoma","No prior Rx"
"GSM3467259","GII-III.10","GSM3467259","Public on Nov 14 2018","Nov 13 2018","Nov 14 2018","SRA","1","IDH-mutant glioma grades II-III_Serum_Exosome","Homo sapiens","sample type: glioblastoma","idh1: mut (IDH2 R172K )","atrx: +","mgmt: Unmeth","1p/19q: 1p/19q codeletion","pre-operation radiology: T2 hyperintensity; FLAIR high signal; contrast enhancement (recurrence)","treatment effect: Hyalinised vessels; siderophages","molecule subtype: small RNA","total RNA","Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science). Then, Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer’s protocol.","Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer’s instructions.","9606","Illumina Casava1.7 software used for basecalling.","Data pre-processing was performed using a pipeline comprising of adapter trimming (cutadapt), followed by genome alignment to human genome hg 19 using Bowtie (18 bp seed, 1 error in seed, quality score sum of mismatches<70). Where multiple best strata alignments existed, tags were randomly assigned to one of those coordinates. Tags were annotated against mirBase 20 and filtered for at most one base error within the tag.","Counts for each miRNA were tabulated and adjusted to counts per million miRNAs passing the mismatch filter.","Supplementary_files_format_and_content: All samples achieved miRNA read counts >45,000 read counts and miRNAs with low abundance (<50 read counts across more than 20% of samples) were removed.","GPL11154","Fatemeh,,Vafaee","f.vafaee@unsw.edu.au","0061403012736","School of Biotechnology and Biomolecular Sciences","University of New South Wales","Gate 11 Botany Street, UNSW Sydney, School of BABS","Sydney","UNSW","2052","Australia","0","Illumina HiSeq 2000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10415977","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5005733","NONE","1p/19q codeletion","+","mut (IDH2 R172K )","Unmeth","small RNA","T2 hyperintensity; FLAIR high signal; contrast enhancement (recurrence)","glioblastoma","Hyalinised vessels; siderophages"
"GSM3467260","HC1","GSM3467260","Public on Nov 14 2018","Nov 13 2018","Nov 14 2018","SRA","1","healthy control_Serum_Exosome","Homo sapiens","sample type: healthy control","molecule subtype: small RNA","","","","","","","total RNA","Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science). Then, Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer’s protocol.","Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer’s instructions.","9606","Illumina Casava1.7 software used for basecalling.","Data pre-processing was performed using a pipeline comprising of adapter trimming (cutadapt), followed by genome alignment to human genome hg 19 using Bowtie (18 bp seed, 1 error in seed, quality score sum of mismatches<70). Where multiple best strata alignments existed, tags were randomly assigned to one of those coordinates. Tags were annotated against mirBase 20 and filtered for at most one base error within the tag.","Counts for each miRNA were tabulated and adjusted to counts per million miRNAs passing the mismatch filter.","Supplementary_files_format_and_content: All samples achieved miRNA read counts >45,000 read counts and miRNAs with low abundance (<50 read counts across more than 20% of samples) were removed.","GPL11154","Fatemeh,,Vafaee","f.vafaee@unsw.edu.au","0061403012736","School of Biotechnology and Biomolecular Sciences","University of New South Wales","Gate 11 Botany Street, UNSW Sydney, School of BABS","Sydney","UNSW","2052","Australia","0","Illumina HiSeq 2000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10415974","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5005734","NONE",NA,NA,NA,NA,"small RNA",NA,"healthy control",NA
"GSM3467261","HC2","GSM3467261","Public on Nov 14 2018","Nov 13 2018","Nov 14 2018","SRA","1","healthy control_Serum_Exosome","Homo sapiens","sample type: healthy control","molecule subtype: small RNA","","","","","","","total RNA","Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science). Then, Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer’s protocol.","Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer’s instructions.","9606","Illumina Casava1.7 software used for basecalling.","Data pre-processing was performed using a pipeline comprising of adapter trimming (cutadapt), followed by genome alignment to human genome hg 19 using Bowtie (18 bp seed, 1 error in seed, quality score sum of mismatches<70). Where multiple best strata alignments existed, tags were randomly assigned to one of those coordinates. Tags were annotated against mirBase 20 and filtered for at most one base error within the tag.","Counts for each miRNA were tabulated and adjusted to counts per million miRNAs passing the mismatch filter.","Supplementary_files_format_and_content: All samples achieved miRNA read counts >45,000 read counts and miRNAs with low abundance (<50 read counts across more than 20% of samples) were removed.","GPL11154","Fatemeh,,Vafaee","f.vafaee@unsw.edu.au","0061403012736","School of Biotechnology and Biomolecular Sciences","University of New South Wales","Gate 11 Botany Street, UNSW Sydney, School of BABS","Sydney","UNSW","2052","Australia","0","Illumina HiSeq 2000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10415972","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5005735","NONE",NA,NA,NA,NA,"small RNA",NA,"healthy control",NA
"GSM3467262","HC3","GSM3467262","Public on Nov 14 2018","Nov 13 2018","Nov 14 2018","SRA","1","healthy control_Serum_Exosome","Homo sapiens","sample type: healthy control","molecule subtype: small RNA","","","","","","","total RNA","Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science). Then, Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer’s protocol.","Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer’s instructions.","9606","Illumina Casava1.7 software used for basecalling.","Data pre-processing was performed using a pipeline comprising of adapter trimming (cutadapt), followed by genome alignment to human genome hg 19 using Bowtie (18 bp seed, 1 error in seed, quality score sum of mismatches<70). Where multiple best strata alignments existed, tags were randomly assigned to one of those coordinates. Tags were annotated against mirBase 20 and filtered for at most one base error within the tag.","Counts for each miRNA were tabulated and adjusted to counts per million miRNAs passing the mismatch filter.","Supplementary_files_format_and_content: All samples achieved miRNA read counts >45,000 read counts and miRNAs with low abundance (<50 read counts across more than 20% of samples) were removed.","GPL11154","Fatemeh,,Vafaee","f.vafaee@unsw.edu.au","0061403012736","School of Biotechnology and Biomolecular Sciences","University of New South Wales","Gate 11 Botany Street, UNSW Sydney, School of BABS","Sydney","UNSW","2052","Australia","0","Illumina HiSeq 2000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10415971","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5005736","NONE",NA,NA,NA,NA,"small RNA",NA,"healthy control",NA
"GSM3467263","HC4","GSM3467263","Public on Nov 14 2018","Nov 13 2018","Nov 14 2018","SRA","1","healthy control_Serum_Exosome","Homo sapiens","sample type: healthy control","molecule subtype: small RNA","","","","","","","total RNA","Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science). Then, Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer’s protocol.","Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer’s instructions.","9606","Illumina Casava1.7 software used for basecalling.","Data pre-processing was performed using a pipeline comprising of adapter trimming (cutadapt), followed by genome alignment to human genome hg 19 using Bowtie (18 bp seed, 1 error in seed, quality score sum of mismatches<70). Where multiple best strata alignments existed, tags were randomly assigned to one of those coordinates. Tags were annotated against mirBase 20 and filtered for at most one base error within the tag.","Counts for each miRNA were tabulated and adjusted to counts per million miRNAs passing the mismatch filter.","Supplementary_files_format_and_content: All samples achieved miRNA read counts >45,000 read counts and miRNAs with low abundance (<50 read counts across more than 20% of samples) were removed.","GPL11154","Fatemeh,,Vafaee","f.vafaee@unsw.edu.au","0061403012736","School of Biotechnology and Biomolecular Sciences","University of New South Wales","Gate 11 Botany Street, UNSW Sydney, School of BABS","Sydney","UNSW","2052","Australia","0","Illumina HiSeq 2000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10415969","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5005737","NONE",NA,NA,NA,NA,"small RNA",NA,"healthy control",NA
"GSM3467264","HC5","GSM3467264","Public on Nov 14 2018","Nov 13 2018","Nov 14 2018","SRA","1","healthy control_Serum_Exosome","Homo sapiens","sample type: healthy control","molecule subtype: small RNA","","","","","","","total RNA","Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science). Then, Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer’s protocol.","Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer’s instructions.","9606","Illumina Casava1.7 software used for basecalling.","Data pre-processing was performed using a pipeline comprising of adapter trimming (cutadapt), followed by genome alignment to human genome hg 19 using Bowtie (18 bp seed, 1 error in seed, quality score sum of mismatches<70). Where multiple best strata alignments existed, tags were randomly assigned to one of those coordinates. Tags were annotated against mirBase 20 and filtered for at most one base error within the tag.","Counts for each miRNA were tabulated and adjusted to counts per million miRNAs passing the mismatch filter.","Supplementary_files_format_and_content: All samples achieved miRNA read counts >45,000 read counts and miRNAs with low abundance (<50 read counts across more than 20% of samples) were removed.","GPL11154","Fatemeh,,Vafaee","f.vafaee@unsw.edu.au","0061403012736","School of Biotechnology and Biomolecular Sciences","University of New South Wales","Gate 11 Botany Street, UNSW Sydney, School of BABS","Sydney","UNSW","2052","Australia","0","Illumina HiSeq 2000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10415967","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5005738","NONE",NA,NA,NA,NA,"small RNA",NA,"healthy control",NA
"GSM3467265","HC6","GSM3467265","Public on Nov 14 2018","Nov 13 2018","Nov 14 2018","SRA","1","healthy control_Serum_Exosome","Homo sapiens","sample type: healthy control","molecule subtype: small RNA","","","","","","","total RNA","Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science). Then, Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer’s protocol.","Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer’s instructions.","9606","Illumina Casava1.7 software used for basecalling.","Data pre-processing was performed using a pipeline comprising of adapter trimming (cutadapt), followed by genome alignment to human genome hg 19 using Bowtie (18 bp seed, 1 error in seed, quality score sum of mismatches<70). Where multiple best strata alignments existed, tags were randomly assigned to one of those coordinates. Tags were annotated against mirBase 20 and filtered for at most one base error within the tag.","Counts for each miRNA were tabulated and adjusted to counts per million miRNAs passing the mismatch filter.","Supplementary_files_format_and_content: All samples achieved miRNA read counts >45,000 read counts and miRNAs with low abundance (<50 read counts across more than 20% of samples) were removed.","GPL11154","Fatemeh,,Vafaee","f.vafaee@unsw.edu.au","0061403012736","School of Biotechnology and Biomolecular Sciences","University of New South Wales","Gate 11 Botany Street, UNSW Sydney, School of BABS","Sydney","UNSW","2052","Australia","0","Illumina HiSeq 2000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10415966","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5005739","NONE",NA,NA,NA,NA,"small RNA",NA,"healthy control",NA
"GSM3467266","HC7","GSM3467266","Public on Nov 14 2018","Nov 13 2018","Nov 14 2018","SRA","1","healthy control_Serum_Exosome","Homo sapiens","sample type: healthy control","molecule subtype: small RNA","","","","","","","total RNA","Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science). Then, Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer’s protocol.","Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer’s instructions.","9606","Illumina Casava1.7 software used for basecalling.","Data pre-processing was performed using a pipeline comprising of adapter trimming (cutadapt), followed by genome alignment to human genome hg 19 using Bowtie (18 bp seed, 1 error in seed, quality score sum of mismatches<70). Where multiple best strata alignments existed, tags were randomly assigned to one of those coordinates. Tags were annotated against mirBase 20 and filtered for at most one base error within the tag.","Counts for each miRNA were tabulated and adjusted to counts per million miRNAs passing the mismatch filter.","Supplementary_files_format_and_content: All samples achieved miRNA read counts >45,000 read counts and miRNAs with low abundance (<50 read counts across more than 20% of samples) were removed.","GPL11154","Fatemeh,,Vafaee","f.vafaee@unsw.edu.au","0061403012736","School of Biotechnology and Biomolecular Sciences","University of New South Wales","Gate 11 Botany Street, UNSW Sydney, School of BABS","Sydney","UNSW","2052","Australia","0","Illumina HiSeq 2000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10415965","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5005740","NONE",NA,NA,NA,NA,"small RNA",NA,"healthy control",NA
"GSM3467267","HC8","GSM3467267","Public on Nov 14 2018","Nov 13 2018","Nov 14 2018","SRA","1","healthy control_Serum_Exosome","Homo sapiens","sample type: healthy control","molecule subtype: small RNA","","","","","","","total RNA","Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science). Then, Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer’s protocol.","Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer’s instructions.","9606","Illumina Casava1.7 software used for basecalling.","Data pre-processing was performed using a pipeline comprising of adapter trimming (cutadapt), followed by genome alignment to human genome hg 19 using Bowtie (18 bp seed, 1 error in seed, quality score sum of mismatches<70). Where multiple best strata alignments existed, tags were randomly assigned to one of those coordinates. Tags were annotated against mirBase 20 and filtered for at most one base error within the tag.","Counts for each miRNA were tabulated and adjusted to counts per million miRNAs passing the mismatch filter.","Supplementary_files_format_and_content: All samples achieved miRNA read counts >45,000 read counts and miRNAs with low abundance (<50 read counts across more than 20% of samples) were removed.","GPL11154","Fatemeh,,Vafaee","f.vafaee@unsw.edu.au","0061403012736","School of Biotechnology and Biomolecular Sciences","University of New South Wales","Gate 11 Botany Street, UNSW Sydney, School of BABS","Sydney","UNSW","2052","Australia","0","Illumina HiSeq 2000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10415964","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5005741","NONE",NA,NA,NA,NA,"small RNA",NA,"healthy control",NA
"GSM3467268","HC9","GSM3467268","Public on Nov 14 2018","Nov 13 2018","Nov 14 2018","SRA","1","healthy control_Serum_Exosome","Homo sapiens","sample type: healthy control","molecule subtype: small RNA","","","","","","","total RNA","Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science). Then, Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer’s protocol.","Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer’s instructions.","9606","Illumina Casava1.7 software used for basecalling.","Data pre-processing was performed using a pipeline comprising of adapter trimming (cutadapt), followed by genome alignment to human genome hg 19 using Bowtie (18 bp seed, 1 error in seed, quality score sum of mismatches<70). Where multiple best strata alignments existed, tags were randomly assigned to one of those coordinates. Tags were annotated against mirBase 20 and filtered for at most one base error within the tag.","Counts for each miRNA were tabulated and adjusted to counts per million miRNAs passing the mismatch filter.","Supplementary_files_format_and_content: All samples achieved miRNA read counts >45,000 read counts and miRNAs with low abundance (<50 read counts across more than 20% of samples) were removed.","GPL11154","Fatemeh,,Vafaee","f.vafaee@unsw.edu.au","0061403012736","School of Biotechnology and Biomolecular Sciences","University of New South Wales","Gate 11 Botany Street, UNSW Sydney, School of BABS","Sydney","UNSW","2052","Australia","0","Illumina HiSeq 2000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10415963","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5005742","NONE",NA,NA,NA,NA,"small RNA",NA,"healthy control",NA
"GSM3467269","HC10","GSM3467269","Public on Nov 14 2018","Nov 13 2018","Nov 14 2018","SRA","1","healthy control_Serum_Exosome","Homo sapiens","sample type: healthy control","molecule subtype: small RNA","","","","","","","total RNA","Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science). Then, Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer’s protocol.","Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer’s instructions.","9606","Illumina Casava1.7 software used for basecalling.","Data pre-processing was performed using a pipeline comprising of adapter trimming (cutadapt), followed by genome alignment to human genome hg 19 using Bowtie (18 bp seed, 1 error in seed, quality score sum of mismatches<70). Where multiple best strata alignments existed, tags were randomly assigned to one of those coordinates. Tags were annotated against mirBase 20 and filtered for at most one base error within the tag.","Counts for each miRNA were tabulated and adjusted to counts per million miRNAs passing the mismatch filter.","Supplementary_files_format_and_content: All samples achieved miRNA read counts >45,000 read counts and miRNAs with low abundance (<50 read counts across more than 20% of samples) were removed.","GPL11154","Fatemeh,,Vafaee","f.vafaee@unsw.edu.au","0061403012736","School of Biotechnology and Biomolecular Sciences","University of New South Wales","Gate 11 Botany Street, UNSW Sydney, School of BABS","Sydney","UNSW","2052","Australia","0","Illumina HiSeq 2000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10415962","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5005743","NONE",NA,NA,NA,NA,"small RNA",NA,"healthy control",NA
"GSM3467270","HC11","GSM3467270","Public on Nov 14 2018","Nov 13 2018","Nov 14 2018","SRA","1","healthy control_Serum_Exosome","Homo sapiens","sample type: healthy control","molecule subtype: small RNA","","","","","","","total RNA","Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science). Then, Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer’s protocol.","Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer’s instructions.","9606","Illumina Casava1.7 software used for basecalling.","Data pre-processing was performed using a pipeline comprising of adapter trimming (cutadapt), followed by genome alignment to human genome hg 19 using Bowtie (18 bp seed, 1 error in seed, quality score sum of mismatches<70). Where multiple best strata alignments existed, tags were randomly assigned to one of those coordinates. Tags were annotated against mirBase 20 and filtered for at most one base error within the tag.","Counts for each miRNA were tabulated and adjusted to counts per million miRNAs passing the mismatch filter.","Supplementary_files_format_and_content: All samples achieved miRNA read counts >45,000 read counts and miRNAs with low abundance (<50 read counts across more than 20% of samples) were removed.","GPL11154","Fatemeh,,Vafaee","f.vafaee@unsw.edu.au","0061403012736","School of Biotechnology and Biomolecular Sciences","University of New South Wales","Gate 11 Botany Street, UNSW Sydney, School of BABS","Sydney","UNSW","2052","Australia","0","Illumina HiSeq 2000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10415961","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5005744","NONE",NA,NA,NA,NA,"small RNA",NA,"healthy control",NA
"GSM3467271","HC12","GSM3467271","Public on Nov 14 2018","Nov 13 2018","Nov 14 2018","SRA","1","healthy control_Serum_Exosome","Homo sapiens","sample type: healthy control","molecule subtype: small RNA","","","","","","","total RNA","Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science). Then, Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer’s protocol.","Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer’s instructions.","9606","Illumina Casava1.7 software used for basecalling.","Data pre-processing was performed using a pipeline comprising of adapter trimming (cutadapt), followed by genome alignment to human genome hg 19 using Bowtie (18 bp seed, 1 error in seed, quality score sum of mismatches<70). Where multiple best strata alignments existed, tags were randomly assigned to one of those coordinates. Tags were annotated against mirBase 20 and filtered for at most one base error within the tag.","Counts for each miRNA were tabulated and adjusted to counts per million miRNAs passing the mismatch filter.","Supplementary_files_format_and_content: All samples achieved miRNA read counts >45,000 read counts and miRNAs with low abundance (<50 read counts across more than 20% of samples) were removed.","GPL11154","Fatemeh,,Vafaee","f.vafaee@unsw.edu.au","0061403012736","School of Biotechnology and Biomolecular Sciences","University of New South Wales","Gate 11 Botany Street, UNSW Sydney, School of BABS","Sydney","UNSW","2052","Australia","0","Illumina HiSeq 2000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10415960","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5005745","NONE",NA,NA,NA,NA,"small RNA",NA,"healthy control",NA
"GSM3467272","HC13","GSM3467272","Public on Nov 14 2018","Nov 13 2018","Nov 14 2018","SRA","1","healthy control_Serum_Exosome","Homo sapiens","sample type: healthy control","molecule subtype: small RNA","","","","","","","total RNA","Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science). Then, Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer’s protocol.","Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer’s instructions.","9606","Illumina Casava1.7 software used for basecalling.","Data pre-processing was performed using a pipeline comprising of adapter trimming (cutadapt), followed by genome alignment to human genome hg 19 using Bowtie (18 bp seed, 1 error in seed, quality score sum of mismatches<70). Where multiple best strata alignments existed, tags were randomly assigned to one of those coordinates. Tags were annotated against mirBase 20 and filtered for at most one base error within the tag.","Counts for each miRNA were tabulated and adjusted to counts per million miRNAs passing the mismatch filter.","Supplementary_files_format_and_content: All samples achieved miRNA read counts >45,000 read counts and miRNAs with low abundance (<50 read counts across more than 20% of samples) were removed.","GPL11154","Fatemeh,,Vafaee","f.vafaee@unsw.edu.au","0061403012736","School of Biotechnology and Biomolecular Sciences","University of New South Wales","Gate 11 Botany Street, UNSW Sydney, School of BABS","Sydney","UNSW","2052","Australia","0","Illumina HiSeq 2000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10415959","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5005746","NONE",NA,NA,NA,NA,"small RNA",NA,"healthy control",NA
"GSM3467273","HC14","GSM3467273","Public on Nov 14 2018","Nov 13 2018","Nov 14 2018","SRA","1","healthy control_Serum_Exosome","Homo sapiens","sample type: healthy control","molecule subtype: small RNA","","","","","","","total RNA","Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science). Then, Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer’s protocol.","Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer’s instructions.","9606","Illumina Casava1.7 software used for basecalling.","Data pre-processing was performed using a pipeline comprising of adapter trimming (cutadapt), followed by genome alignment to human genome hg 19 using Bowtie (18 bp seed, 1 error in seed, quality score sum of mismatches<70). Where multiple best strata alignments existed, tags were randomly assigned to one of those coordinates. Tags were annotated against mirBase 20 and filtered for at most one base error within the tag.","Counts for each miRNA were tabulated and adjusted to counts per million miRNAs passing the mismatch filter.","Supplementary_files_format_and_content: All samples achieved miRNA read counts >45,000 read counts and miRNAs with low abundance (<50 read counts across more than 20% of samples) were removed.","GPL11154","Fatemeh,,Vafaee","f.vafaee@unsw.edu.au","0061403012736","School of Biotechnology and Biomolecular Sciences","University of New South Wales","Gate 11 Botany Street, UNSW Sydney, School of BABS","Sydney","UNSW","2052","Australia","0","Illumina HiSeq 2000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10415958","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5005747","NONE",NA,NA,NA,NA,"small RNA",NA,"healthy control",NA
"GSM3467274","HC15","GSM3467274","Public on Nov 14 2018","Nov 13 2018","Nov 14 2018","SRA","1","healthy control_Serum_Exosome","Homo sapiens","sample type: healthy control","molecule subtype: small RNA","","","","","","","total RNA","Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science). Then, Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer’s protocol.","Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer’s instructions.","9606","Illumina Casava1.7 software used for basecalling.","Data pre-processing was performed using a pipeline comprising of adapter trimming (cutadapt), followed by genome alignment to human genome hg 19 using Bowtie (18 bp seed, 1 error in seed, quality score sum of mismatches<70). Where multiple best strata alignments existed, tags were randomly assigned to one of those coordinates. Tags were annotated against mirBase 20 and filtered for at most one base error within the tag.","Counts for each miRNA were tabulated and adjusted to counts per million miRNAs passing the mismatch filter.","Supplementary_files_format_and_content: All samples achieved miRNA read counts >45,000 read counts and miRNAs with low abundance (<50 read counts across more than 20% of samples) were removed.","GPL11154","Fatemeh,,Vafaee","f.vafaee@unsw.edu.au","0061403012736","School of Biotechnology and Biomolecular Sciences","University of New South Wales","Gate 11 Botany Street, UNSW Sydney, School of BABS","Sydney","UNSW","2052","Australia","0","Illumina HiSeq 2000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10415957","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5005748","NONE",NA,NA,NA,NA,"small RNA",NA,"healthy control",NA
"GSM3467275","HC16","GSM3467275","Public on Nov 14 2018","Nov 13 2018","Nov 14 2018","SRA","1","healthy control_Serum_Exosome","Homo sapiens","sample type: healthy control","molecule subtype: small RNA","","","","","","","total RNA","Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science). Then, Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer’s protocol.","Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer’s instructions.","9606","Illumina Casava1.7 software used for basecalling.","Data pre-processing was performed using a pipeline comprising of adapter trimming (cutadapt), followed by genome alignment to human genome hg 19 using Bowtie (18 bp seed, 1 error in seed, quality score sum of mismatches<70). Where multiple best strata alignments existed, tags were randomly assigned to one of those coordinates. Tags were annotated against mirBase 20 and filtered for at most one base error within the tag.","Counts for each miRNA were tabulated and adjusted to counts per million miRNAs passing the mismatch filter.","Supplementary_files_format_and_content: All samples achieved miRNA read counts >45,000 read counts and miRNAs with low abundance (<50 read counts across more than 20% of samples) were removed.","GPL11154","Fatemeh,,Vafaee","f.vafaee@unsw.edu.au","0061403012736","School of Biotechnology and Biomolecular Sciences","University of New South Wales","Gate 11 Botany Street, UNSW Sydney, School of BABS","Sydney","UNSW","2052","Australia","0","Illumina HiSeq 2000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10415956","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5005749","NONE",NA,NA,NA,NA,"small RNA",NA,"healthy control",NA
